10 20 30 40 50 60 70 80 1ODC - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 15-FEB-03 1ODC
TITLE STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED TITLE 2 WITH N-4'-QUINOLYL-N'-9"-(1",2",3",4" TITLE 3 -TETRAHYDROACRIDINYL)-1,8-DIAMINOOCTANE AT 2.2A RESOLUTION
COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACETYLCHOLINESTERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACHE; COMPND 5 EC: 3.1.1.7; COMPND 6 OTHER_DETAILS: INTER-MONOMER DISULFIDE BRIDGE
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TORPEDO CALIFORNICA; SOURCE 3 ORGANISM_COMMON: PACIFIC ELECTRIC RAY; SOURCE 4 ORGANISM_TAXID: 7787; SOURCE 5 VARIANT: G2 FORM; SOURCE 6 ORGAN: ELECTRIC ORGAN; SOURCE 7 TISSUE: ELECTROPLAQUE; SOURCE 8 OTHER_DETAILS: SYNTHETIC HETEROBIVALENT TACRINE-BASED SOURCE 9 DIMER, A8B (N-4'-QUINOLYL-N'-9"-(1", 2", 3", 4" SOURCE 10 -TETRAHYDROACRIDINYL)-1, 8-DIAMINOOCTANE) DIHYDROCHLORIDE SOURCE 11 WITH THE TACRINE MOIETY BOUND TO THE 'ANIONIC' SUBSITE, SOURCE 12 NEAR THE BOTTOM OF THE ACTIVE SITE GORGE, AND THE SOURCE 13 4-AMINOQUINOLINE MOIETY BOUND TO THE 'PERIPHERAL' ANIONIC SOURCE 14 SITE (PAS) AT THE TOP OF THE GORGE OF TCACHE, BOTH IN A SOURCE 15 DOUBLE-STACKING SANDWICH. THE LIGAND, A8B, THUS BINDS BY SOURCE 16 SPANNING THE ACTIVE-SITE GORGE.
KEYWDS HYDROLASE, SERINE HYDROLASE, NEUROTRANSMITTER CLEAVAGE, KEYWDS 2 ALZHEIMER'S DISEASE, BIVALENT LIGAND, DUAL-SITE BINDING, KEYWDS 3 INHIBITOR, SERINE ESTERASE SYNAPSE, NERVE, MUSCLE, KEYWDS 4 GPI-ANCHOR NEUROTRANSMITTER DEGRADATION, GLYCOPROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR D.M.WONG,H.M.GREENBLATT,P.R.CARLIER,Y.-F.HAN,Y.-P.PANG, AUTHOR 2 I.SILMAN,J.L.SUSSMAN
REVDAT 4 02-FEB-10 1ODC 1 VERSN REVDAT 3 24-FEB-09 1ODC 1 VERSN REVDAT 2 06-SEP-06 1ODC 1 JRNL REVDAT 1 23-MAR-05 1ODC 0
JRNL AUTH E.H.RYDBERG,B.BRUMSHTEIN,H.M.GREENBLATT,D.M.WONG, JRNL AUTH 2 D.SHAYA,L.D.WILLIAMS,P.R.CARLIER,Y.-P.PANG, JRNL AUTH 3 I.SILMAN,J.L.SUSSMAN JRNL TITL COMPLEXES OF ALKYLENE-LINKED TACRINE DIMERS WITH JRNL TITL 2 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE: BINDING JRNL TITL 3 OF BIS(5)-TACRINE PRODUCES A DRAMATIC JRNL TITL 4 REARRANGEMENT IN THE ACTIVE-SITE GORGE. JRNL REF J.MED.CHEM. V. 49 5491 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 16942022 JRNL DOI 10.1021/JM060164B
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.M.WONG,H.M.GREENBLATT,H.DVIR,P.R.CARLIER, REMARK 1 AUTH 2 Y.-F.HAN,Y.-P.PANG,I.SILMAN,J.L.SUSSMAN REMARK 1 TITL ACETYLCHOLINESTERASE COMPLEXED WITH BIVALENT REMARK 1 TITL 2 LIGANDS RELATED TO HUPERZINE A: EXPERIMENTAL REMARK 1 TITL 3 EVIDENCE FOR SPECIES-DEPENDENT PROTEIN-LIGAND REMARK 1 TITL 4 COMPLEMENTARITY REMARK 1 REF J.AM.CHEM.SOC. V. 125 363 2003 REMARK 1 REFN ISSN 0002-7863 REMARK 1 PMID 12517147 REMARK 1 DOI 10.1021/JA021111W REMARK 1 REFERENCE 2 REMARK 1 AUTH P.R.CARLIER,E.S.-H.CHOW,Y.-F.HAN,J.LIU,J.EL YAZAL, REMARK 1 AUTH 2 Y.-P.PANG REMARK 1 TITL HETERODIMERIC TACRINE-BASED ACETYLCHOLINESTERASE REMARK 1 TITL 2 INHIBITORS: INVESTIGATING LIGAND-PERIPHERAL SITE REMARK 1 TITL 3 INTERACTIONS REMARK 1 REF J.MED.CHEM. V. 42 4225 1999 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 10514292 REMARK 1 DOI 10.1021/JM990224W REMARK 1 REFERENCE 3 REMARK 1 AUTH Y.-P.PANG,A.P.KOZIKOWSKI REMARK 1 TITL PREDICTION OF THE BINDING SITES OF HUPERZINE A IN REMARK 1 TITL 2 ACETYLCHOLINESTERASE BY DOCKING STUDIES REMARK 1 REF J. COMPUT. AIDED MOL. DES. V. 8 669 1994 REMARK 1 REFN ISSN 0920-654X REMARK 1 PMID 7738603 REMARK 1 DOI 10.1007/BF00124014 REMARK 1 REFERENCE 4 REMARK 1 AUTH M.HAREL,I.SCHALK,L.EHRET-SABATIER,F.BOUET, REMARK 1 AUTH 2 M.GOELDNER,C.HIRTH,P.H.AXELSEN,I.SILMAN,J.L.SUSSMAN REMARK 1 TITL QUATERNARY LIGAND BINDING TO AROMATIC RESIDUES IN REMARK 1 TITL 2 THE ACTIVE-SITE GORGE OF ACETYLCHOLINESTERASE REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 90 9031 1993 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 8415649 REMARK 1 DOI 10.1073/PNAS.90.19.9031 REMARK 1 REFERENCE 5 REMARK 1 AUTH J.L.SUSSMAN,M.HAREL,F.FROLOW,C.OEFNER,A.GOLDMAN, REMARK 1 AUTH 2 L.TOKER,I.SILMAN REMARK 1 TITL ATOMIC STRUCTURE OF ACETYLCHOLINESTERASE FROM REMARK 1 TITL 2 TORPEDO CALIFORNICA: A PROTOTYPIC REMARK 1 TITL 3 ACETYLCHOLINE-BINDING PROTEIN REMARK 1 REF SCIENCE V. 253 872 1991 REMARK 1 REFN ISSN 0036-8075 REMARK 1 PMID 1678899 REMARK 1 DOI 10.1126/SCIENCE.1678899
REMARK 2 REMARK 2 RESOLUTION. 2.2 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.12 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2034289.24 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 49443 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.1991 REMARK 3 FREE R VALUE : 0.2401 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.9 REMARK 3 FREE R VALUE TEST SET COUNT : 2428 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.1 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4544 REMARK 3 BIN R VALUE (WORKING SET) : 0.234 REMARK 3 BIN FREE R VALUE : 0.226 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.9 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 225 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4178 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 153 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.4 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.2 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.03 REMARK 3 B22 (A**2) : 7.03 REMARK 3 B33 (A**2) : -14.04 REMARK 3 B12 (A**2) : 3.07 REMARK 3 B13 (A**2) : 0.000 REMARK 3 B23 (A**2) : 0.000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.14 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.020 REMARK 3 BOND ANGLES (DEGREES) : 1.9 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.0 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.27 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.233 ; 1.50 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.811 ; 2.00 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.153 ; 2.00 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.994 ; 2.50 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 51.6 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : A8B_1.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : CIS_PEPTIDE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : A8B.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SEVERAL RESIDUES ARE NOT SEEN IN THE REMARK 3 CRYSTAL STRUCTURE, DUE TO DISORDER. THESE INCLUDE ASP 1, ASP REMARK 3 2, HIS 3 AND THE C-TERMINAL RESIDUES AFTER ALA 536. SEVERAL REMARK 3 RESIDUES MISSING IN CHAIN BREAK, FROM HIS 486 - GLU 489 REMARK 3 (INCLUSIVE). TWO WATER MOLECULES WERE FITTED WITH 0.75 REMARK 3 OCCUPANCIES EACH (HOH Z 152 AND HOH Z 153).
REMARK 4 REMARK 4 1ODC COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-FEB-03. REMARK 100 THE PDBE ID CODE IS EBI-12137.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-00 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : 5.80 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC BLUE CONFOCAL MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50284 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 0.350 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 9.81 REMARK 200 R MERGE FOR SHELL (I) : 0.28700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2ACE REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.7 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLISED FROM REMARK 280 28-33% V/V PEG 200 0.5M MES PH 5.8 AT 4 DEG. CELSIUS; THEN REMARK 280 SOAKED IN MOTHER LIQUOR (40% V/V PEG 200 IN 0.1 M MES REMARK 280 BUFFER, PH 5.8) CONTAINING 1MM N-4'-QUINOLYL-N'-9"-(1",2", REMARK 280 3",4"-TETRAHYDROACRIDINYL)-1,8-DIAMINOOCTANE DIHYRDOCHLORIDE REMARK 280 FOR ONE DAY.
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.58133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 91.16267 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 91.16267 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.58133 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400 REMARK 400 COMPOUND REMARK 400 COMPOUND HYDROLYZES CHOLINE RELEASED INTO THE SYNAPSE. REMARK 400 CATALYTIC ACTIVITY: ACETYLCHOLINE + H(2)O = CHOLINE REMARK 400 ACETATE. INHIBITORS OF THE ENZYME ACETYLCHOLINESTERASE REMARK 400 (ACHE) IMPROVE THE COGNITIVE ABILITIES OF INDIVIDUALS WITH REMARK 400 EARLY STAGE ALZHEIMER'S DISEASE. 9-AMINO-1,2,3,4-TETRA- REMARK 400 HYDROACRIDINE (TACRINE, ALSO KNOWN AS THA OR COGNEX), A REMARK 400 SYNTHETIC COMPOUND, IS AMONG THE POTENT ACHE INHIBITORS REMARK 400 USED IN THIS TREATMENT. THE LIGAND, A8B REMARK 400 (N-4'-QUINOLYL-N'- 9"-(1",2",3",4" REMARK 400 -TETRA-HYDROACRIDINYL)-1,8-DIAMINOOCTANE) DIHYDROCHLORIDE, REMARK 400 A C8-ALKYLENE LINKED HETERODIMER OF TACRINE AND REMARK 400 4-AMINOQUINOLINE, WAS DESIGNED TO PROBE THE PROTEIN-LIGAND REMARK 400 INTERACTIONS AT THE 'PERIPHEAL' ANIONIC REMARK 400 SITE (PAS) OF THE ACTIVE-SITE GORGE OF ACHE. IT HAS BEEN REMARK 400 SHOWN TO EXHIBIT POTENT INHIBITION OF ACHE. THE TACRINE REMARK 400 MOIETY BINDS TO THE 'ANIONIC' SUBSITE, NEAR THE BOTTOM OF REMARK 400 THE ACTIVE-SITE GORGE OF TCACHE, BETWEEN THE AROMATIC RINGS REMARK 400 OF TRP84 AND PHE330, AS SEEN FOR THE TCACHE/TACRINE REMARK 400 COMPLEX, AND THE 4-AMINOQUINOLINE MOIETY BINDS TO THE PAS REMARK 400 AT THE TOP OF THE GORGE, BETWEEN THE AROMATIC RINGS OF REMARK 400 TRP279 AND TYR70. THE LIGAND, A8B, THUS BINDS BY SPANNING REMARK 400 THE ACTIVE SITE GORGE, WITH BOTH BINDING MOIETIES OF A8B REMARK 400 BINDING IN A DOUBLE-STACKING SANDWICH.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ASP A 2 REMARK 465 HIS A 3 REMARK 465 HIS A 486 REMARK 465 SER A 487 REMARK 465 GLN A 488 REMARK 465 GLU A 489 REMARK 465 CYS A 537 REMARK 465 ASP A 538 REMARK 465 GLY A 539 REMARK 465 GLU A 540 REMARK 465 LEU A 541 REMARK 465 SER A 542 REMARK 465 SER A 543
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 52 CD CE NZ REMARK 470 LYS A 192 CD CE NZ REMARK 470 GLU A 260 CD OE1 OE2 REMARK 470 GLU A 268 OE1 OE2 REMARK 470 LYS A 270 CE NZ REMARK 470 GLU A 299 CG CD OE1 OE2 REMARK 470 GLU A 350 OE1 REMARK 470 LYS A 413 CD CE NZ REMARK 470 GLU A 434 OE2 REMARK 470 LYS A 454 CG CD CE NZ REMARK 470 LYS A 498 CD CE NZ REMARK 470 GLU A 508 OE2 REMARK 470 LYS A 511 CD CE NZ REMARK 470 ALA A 536 CA C O CB
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET A 175 SD MET A 175 CE -0.361 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 221 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG A 243 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG A 243 NE - CZ - NH2 ANGL. DEV. = -5.3 DEGREES REMARK 500 LEU A 494 CA - CB - CG ANGL. DEV. = 14.2 DEGREES REMARK 500 VAL A 518 CB - CA - C ANGL. DEV. = -14.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 25 -157.89 -138.41 REMARK 500 PHE A 45 -12.00 83.90 REMARK 500 CYS A 94 12.91 -143.38 REMARK 500 SER A 108 75.51 -164.49 REMARK 500 SER A 200 -125.40 54.18 REMARK 500 GLU A 299 -72.88 -123.33 REMARK 500 THR A 317 -161.47 -164.78 REMARK 500 ASP A 380 51.15 -156.28 REMARK 500 VAL A 400 -60.43 -131.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 442 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 LYS A 491 24.4 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A1536 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A1537 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A8B A1538
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZGB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TORPEDO REMARK 900 CALIFORNICAACETYLCHOLINESTERASE IN COMPLEX WITH REMARK 900 AN (R)-TACRINE(10)-HUPYRIDONE INHIBITOR. REMARK 900 RELATED ID: 1AMN RELATED DB: PDB REMARK 900 TRANSITION STATE ANALOG: ACETYLCHOLINESTERASE REMARK 900 COMPLEXED WITH M-(N,N,N-TRIMETHYLAMMONIO) REMARK 900 TRIFLUOROACETOPHENONE REMARK 900 RELATED ID: 1QTI RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1E66 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH REMARK 900 (-)-HUPRINE X AT 2.1A RESOLUTION REMARK 900 RELATED ID: 2J3D RELATED DB: PDB REMARK 900 NATIVE MONOCLINIC FORM OF TORPEDO REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 2VQ6 RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED REMARK 900 WITH 2-PAM REMARK 900 RELATED ID: 2ACK RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, REMARK 900 MONOCHROMATIC DATA REMARK 900 RELATED ID: 1QII RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT F) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 2CKM RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED REMARK 900 WITH ALKYLENE-LINKED BIS-TACRINE DIMER (7 REMARK 900 CARBON LINKER) REMARK 900 RELATED ID: 1DX6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH REMARK 900 (-)-GALANTHAMINE AT 2.3A RESOLUTION REMARK 900 RELATED ID: 1QIE RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT B) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIJ RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT G) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1ACL RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH DECAMETHONIUM REMARK 900 RELATED ID: 1W4L RELATED DB: PDB REMARK 900 COMPLEX OF TCACHE WITH BIS-ACTING REMARK 900 GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 2CMF RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED REMARK 900 WITH ALKYLENE-LINKED BIS-TACRINE DIMER (5 REMARK 900 CARBON LINKER) REMARK 900 RELATED ID: 2WG0 RELATED DB: PDB REMARK 900 AGED CONJUGATE OF TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE WITH SOMAN (OBTAINED BY REMARK 900 IN CRYSTALLO AGING) REMARK 900 RELATED ID: 1GQS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C. 3.1.1.7) REMARK 900 COMPLEXED WITH NAP REMARK 900 RELATED ID: 2J3Q RELATED DB: PDB REMARK 900 TORPEDO ACETYLCHOLINESTERASE COMPLEXED WITH REMARK 900 FLUOROPHORE THIOFLAVIN T REMARK 900 RELATED ID: 1E3Q RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED REMARK 900 WITH BW284C51 REMARK 900 RELATED ID: 2J4F RELATED DB: PDB REMARK 900 TORPEDO ACETYLCHOLINESTERASE - HG HEAVY-ATOM REMARK 900 DERIVATIVE REMARK 900 RELATED ID: 1QIK RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT H) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 2DFP RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF AGED DI-ISOPROPYL- REMARK 900 PHOSPHORO-FLUORIDATE (DFP) BOUND TO REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 2C5F RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH A NON HYDROLYSABLE SUBSTRATE REMARK 900 ANALOGUE, 4-OXO-N,N,N-TRIMETHYLAMMONIUM REMARK 900 RELATED ID: 1EA5 RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE (E.C. 3.1.1.7 REMARK 900 ) FROM TORPEDO CALIFORNICA AT 1.8A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1EEA RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 2VJC RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH A NON HYDROLYSABLE SUBSTRATE REMARK 900 ANALOGUE, 4-OXO-N,N,N- REMARK 900 TRIMETHYLPENTANAMINIUM - ORTHORHOMBIC SPACE GROUP REMARK 900 - DATASET A AT 150K REMARK 900 RELATED ID: 1QIF RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT C) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 2VJB RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH A NON HYDROLYSABLE SUBSTRATE REMARK 900 ANALOGUE, 4-OXO-N,N,N- REMARK 900 TRIMETHYLPENTANAMINIUM - ORTHORHOMBIC SPACE GROUP REMARK 900 - DATASET D AT 100K REMARK 900 RELATED ID: 1QIG RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT D) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1ZGC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TORPEDO REMARK 900 CALIFORNICAACETYLCHOLINESTERASE IN COMPLEX WITH REMARK 900 AN (RS)-TACRINE(10)-HUPYRIDONE INHIBITOR. REMARK 900 RELATED ID: 1QID RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT A) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 2WFZ RELATED DB: PDB REMARK 900 NON-AGED CONJUGATE OF TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE WITH SOMAN REMARK 900 RELATED ID: 1JJB RELATED DB: PDB REMARK 900 A NEUTRAL MOLECULE IN CATION-BINDING SITE: REMARK 900 SPECIFIC BINDINGOF PEG-SH TO REMARK 900 ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA REMARK 900 RELATED ID: 2VJD RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH A NON HYDROLYSABLE SUBSTRATE REMARK 900 ANALOGUE, 4-OXO-N,N,N- REMARK 900 TRIMETHYLPENTANAMINIUM - ORTHORHOMBIC SPACE GROUP REMARK 900 - DATASET C AT 150K REMARK 900 RELATED ID: 1UT6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 REMARK 900 .1.7) COMPLEXED WITH N-9-(1',2',3',4 REMARK 900 '-TETRAHYDROACRIDINYL)-1,8- DIAMINOOCTANE AT REMARK 900 2.4 ANGSTROMS RESOLUTION. REMARK 900 RELATED ID: 2WG1 RELATED DB: PDB REMARK 900 TERNARY COMPLEX OF THE AGED CONJUGATE OF REMARK 900 TORPEDO CALIFORNICA ACEYLCHOLINESTERASE WITH REMARK 900 SOMAN AND 2-PAM REMARK 900 RELATED ID: 2VT6 RELATED DB: PDB REMARK 900 NATIVE TORPEDO CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 COLLECTED WITH A CUMULATED DOSE OF 9400000 REMARK 900 GY REMARK 900 RELATED ID: 2W9I RELATED DB: PDB REMARK 900 ACHE IN COMPLEX WITH METHYLENE BLUE REMARK 900 RELATED ID: 2WG2 RELATED DB: PDB REMARK 900 NON-AGED CONJUGATE OF TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE WITH SOMAN (ALTERNATIVE REMARK 900 REFINEMENT) REMARK 900 RELATED ID: 2VT7 RELATED DB: PDB REMARK 900 NATIVE TORPEDO CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 COLLECTED WITH A CUMULATED DOSE OF 800000 REMARK 900 GY REMARK 900 RELATED ID: 2CEK RELATED DB: PDB REMARK 900 CONFORMATIONAL FLEXIBILITY IN THE PERIPHERAL REMARK 900 SITE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 REVEALED BY THE COMPLEX STRUCTURE WITH A REMARK 900 BIFUNCTIONAL INHIBITOR REMARK 900 RELATED ID: 1QIM RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT I) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1GPK RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXE WITH REMARK 900 (+)-HUPERZINE A AT 2.1A RESOLUTION REMARK 900 RELATED ID: 1JGA RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,7- REMARK 900 HEPTYLENE-BIS-N,N'-SYN-2-PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 3ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (R)-E2020 BOUND REMARK 900 ACETYLCHOLINESTERASE COMPLEX, 3 STRUCTURES REMARK 900 RELATED ID: 1W6R RELATED DB: PDB REMARK 900 COMPLEX OF TCACHE WITH GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1OCE RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH MF268 REMARK 900 RELATED ID: 1SOM RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED REMARK 900 BY NERVE AGENT GD (SOMAN). REMARK 900 RELATED ID: 1VXO RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) REMARK 900 OBTAINED BY REACTION WITH O-ETHYL-S-[2-[ REMARK 900 BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 2W6C RELATED DB: PDB REMARK 900 ACHE IN COMPLEX WITH A BIS-(-)-NOR- REMARK 900 MEPTAZINOL DERIVATIVE REMARK 900 RELATED ID: 2VJA RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH A NON HYDROLYSABLE SUBSTRATE REMARK 900 ANALOGUE, 4-OXO-N,N,N- REMARK 900 TRIMETHYLPENTANAMINIUM - ORTHORHOMBIC SPACE GROUP REMARK 900 - DATASET A AT 100K REMARK 900 RELATED ID: 1CFJ RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) REMARK 900 OBTAINED BY REACTION WITH O- REMARK 900 ISOPROPYLMETHYLPHOSPHONOFLUORIDATE (GB, SARIN) REMARK 900 RELATED ID: 2V96 RELATED DB: PDB REMARK 900 STRUCTURE OF THE UNPHOTOLYSED COMPLEX OF REMARK 900 TCACHE WITH 1-(2-NITROPHENYL)-2,2,2- REMARK 900 TRIFLUOROETHYL-ARSENOCHOLINE AT 100K REMARK 900 RELATED ID: 1U65 RELATED DB: PDB REMARK 900 ACHE W. CPT-11 REMARK 900 RELATED ID: 1AX9 RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, REMARK 900 LAUE DATA REMARK 900 RELATED ID: 1W76 RELATED DB: PDB REMARK 900 ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE (ACHE) COMPLEXED WITH BIS- REMARK 900 ACTING GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1H22 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 REMARK 900 .1.7) COMPLEXED WITH (S,S)-(-)-BIS(10)- REMARK 900 HUPERZINE A-LIKE INHIBITOR AT 2.15A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1EVE RELATED DB: PDB REMARK 900 THREE DIMENSIONAL STRUCTURE OF THE ANTI- REMARK 900 ALZHEIMER DRUG, E2020 (ARICEPT), COMPLEXED REMARK 900 WITH ITS TARGET ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 2C4H RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH 500MM ACETYLTHIOCHOLINE REMARK 900 RELATED ID: 2VA9 RELATED DB: PDB REMARK 900 STRUCTURE OF NATIVE TCACHE AFTER A 9 REMARK 900 SECONDS ANNEALING TO ROOM TEMPERATURE DURING REMARK 900 THE FIRST 5 SECONDS OF WHICH LASER REMARK 900 IRRADIATION AT 266NM TOOK PLACE REMARK 900 RELATED ID: 1GQR RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C. 3.1.1.7) REMARK 900 COMPLEXED WITH RIVASTIGMINE REMARK 900 RELATED ID: 2ACE RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE FROM TORPEDO REMARK 900 CALIFORNICA REMARK 900 RELATED ID: 1VXR RELATED DB: PDB REMARK 900 O-ETHYLMETHYLPHOSPHONYLATED ACETYLCHOLINESTERASE REMARK 900 OBTAINED BY REACTION WITH O-ETHYL-S-[2-[ REMARK 900 BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 4ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (S)-E2020 BOUND REMARK 900 ACETYLCHOLINESTERASE COMPLEX, 3 STRUCTURES REMARK 900 RELATED ID: 2C58 RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH 20MM ACETYLTHIOCHOLINE REMARK 900 RELATED ID: 1HBJ RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF COMPLEX BETWEEN REMARK 900 TORPEDO CALIFORNICA ACHE AND A REVERSIBLE REMARK 900 INHIBITOR, 4-AMINO-5-FLUORO-2-METHYL-3-( REMARK 900 3-TRIFLUOROACETYLBENZYLTHIOMETHYL)QUINOLINE REMARK 900 RELATED ID: 1VOT RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE A REMARK 900 RELATED ID: 1W75 RELATED DB: PDB REMARK 900 NATIVE ORTHORHOMBIC FORM OF TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE (ACHE) REMARK 900 RELATED ID: 2C5G RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH 20MM THIOCHOLINE REMARK 900 RELATED ID: 1JGB RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,3- REMARK 900 PROPYLENE-BIS-N,N'-SYN-4-PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 2V98 RELATED DB: PDB REMARK 900 STRUCTURE OF THE COMPLEX OF TCACHE WITH 1 REMARK 900 -(2-NITROPHENYL)-2,2,2-TRIFLUOROETHYL- REMARK 900 ARSENOCHOLINE AFTER A 9 SECONDS ANNEALING TO REMARK 900 ROOM TEMPERATURE, DURING HTE FIRST 5 REMARK 900 SECONDS OF WHICH LASER IRRADIATION AT 266NM REMARK 900 TOOK PLACE REMARK 900 RELATED ID: 1GPN RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH REMARK 900 HUPERZINE B AT 2.35A RESOLUTION REMARK 900 RELATED ID: 1QIH RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT REMARK 900 NINE TIME POINTS (POINT E) CAUSED BY REMARK 900 INTENSE SYNCHROTRON RADIATION TO TORPEDO REMARK 900 CALIFORNICA ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 2VB4 RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED REMARK 900 WITH 2-PAM REMARK 900 RELATED ID: 1H23 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 REMARK 900 .1.7) COMPLEXED WITH (S,S)-(-)-BIS(12)- REMARK 900 HUPERZINE A-LIKE INHIBITOR AT 2.15A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1ACJ RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH TACRINE REMARK 900 RELATED ID: 1FSS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN- REMARK 900 II REMARK 900 RELATED ID: 2V97 RELATED DB: PDB REMARK 900 STRUCTURE OF THE UNPHOTOLYSED COMPLEX OF REMARK 900 TCACHE WITH 1-(2-NITROPHENYL)-2,2,2- REMARK 900 TRIFLUOROETHYL-ARSENOCHOLINE AFTER A 9 SECONDS REMARK 900 ANNEALING TO ROOM TEMPERATURE
DBREF 1ODC A 1 543 UNP P04058 ACES_TORCA 22 564
SEQRES 1 A 543 ASP ASP HIS SER GLU LEU LEU VAL ASN THR LYS SER GLY SEQRES 2 A 543 LYS VAL MET GLY THR ARG VAL PRO VAL LEU SER SER HIS SEQRES 3 A 543 ILE SER ALA PHE LEU GLY ILE PRO PHE ALA GLU PRO PRO SEQRES 4 A 543 VAL GLY ASN MET ARG PHE ARG ARG PRO GLU PRO LYS LYS SEQRES 5 A 543 PRO TRP SER GLY VAL TRP ASN ALA SER THR TYR PRO ASN SEQRES 6 A 543 ASN CYS GLN GLN TYR VAL ASP GLU GLN PHE PRO GLY PHE SEQRES 7 A 543 SER GLY SER GLU MET TRP ASN PRO ASN ARG GLU MET SER SEQRES 8 A 543 GLU ASP CYS LEU TYR LEU ASN ILE TRP VAL PRO SER PRO SEQRES 9 A 543 ARG PRO LYS SER THR THR VAL MET VAL TRP ILE TYR GLY SEQRES 10 A 543 GLY GLY PHE TYR SER GLY SER SER THR LEU ASP VAL TYR SEQRES 11 A 543 ASN GLY LYS TYR LEU ALA TYR THR GLU GLU VAL VAL LEU SEQRES 12 A 543 VAL SER LEU SER TYR ARG VAL GLY ALA PHE GLY PHE LEU SEQRES 13 A 543 ALA LEU HIS GLY SER GLN GLU ALA PRO GLY ASN VAL GLY SEQRES 14 A 543 LEU LEU ASP GLN ARG MET ALA LEU GLN TRP VAL HIS ASP SEQRES 15 A 543 ASN ILE GLN PHE PHE GLY GLY ASP PRO LYS THR VAL THR SEQRES 16 A 543 ILE PHE GLY GLU SER ALA GLY GLY ALA SER VAL GLY MET SEQRES 17 A 543 HIS ILE LEU SER PRO GLY SER ARG ASP LEU PHE ARG ARG SEQRES 18 A 543 ALA ILE LEU GLN SER GLY SER PRO ASN CYS PRO TRP ALA SEQRES 19 A 543 SER VAL SER VAL ALA GLU GLY ARG ARG ARG ALA VAL GLU SEQRES 20 A 543 LEU GLY ARG ASN LEU ASN CYS ASN LEU ASN SER ASP GLU SEQRES 21 A 543 GLU LEU ILE HIS CYS LEU ARG GLU LYS LYS PRO GLN GLU SEQRES 22 A 543 LEU ILE ASP VAL GLU TRP ASN VAL LEU PRO PHE ASP SER SEQRES 23 A 543 ILE PHE ARG PHE SER PHE VAL PRO VAL ILE ASP GLY GLU SEQRES 24 A 543 PHE PHE PRO THR SER LEU GLU SER MET LEU ASN SER GLY SEQRES 25 A 543 ASN PHE LYS LYS THR GLN ILE LEU LEU GLY VAL ASN LYS SEQRES 26 A 543 ASP GLU GLY SER PHE PHE LEU LEU TYR GLY ALA PRO GLY SEQRES 27 A 543 PHE SER LYS ASP SER GLU SER LYS ILE SER ARG GLU ASP SEQRES 28 A 543 PHE MET SER GLY VAL LYS LEU SER VAL PRO HIS ALA ASN SEQRES 29 A 543 ASP LEU GLY LEU ASP ALA VAL THR LEU GLN TYR THR ASP SEQRES 30 A 543 TRP MET ASP ASP ASN ASN GLY ILE LYS ASN ARG ASP GLY SEQRES 31 A 543 LEU ASP ASP ILE VAL GLY ASP HIS ASN VAL ILE CYS PRO SEQRES 32 A 543 LEU MET HIS PHE VAL ASN LYS TYR THR LYS PHE GLY ASN SEQRES 33 A 543 GLY THR TYR LEU TYR PHE PHE ASN HIS ARG ALA SER ASN SEQRES 34 A 543 LEU VAL TRP PRO GLU TRP MET GLY VAL ILE HIS GLY TYR SEQRES 35 A 543 GLU ILE GLU PHE VAL PHE GLY LEU PRO LEU VAL LYS GLU SEQRES 36 A 543 LEU ASN TYR THR ALA GLU GLU GLU ALA LEU SER ARG ARG SEQRES 37 A 543 ILE MET HIS TYR TRP ALA THR PHE ALA LYS THR GLY ASN SEQRES 38 A 543 PRO ASN GLU PRO HIS SER GLN GLU SER LYS TRP PRO LEU SEQRES 39 A 543 PHE THR THR LYS GLU GLN LYS PHE ILE ASP LEU ASN THR SEQRES 40 A 543 GLU PRO MET LYS VAL HIS GLN ARG LEU ARG VAL GLN MET SEQRES 41 A 543 CYS VAL PHE TRP ASN GLN PHE LEU PRO LYS LEU LEU ASN SEQRES 42 A 543 ALA THR ALA CYS ASP GLY GLU LEU SER SER
HET NAG A1536 14 HET NAG A1537 14 HET A8B A1538 34
HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM A8B N-QUINOLIN-4-YL-N'-(1,2,3,4- HETNAM 2 A8B TETRAHYDROACRIDIN-9-YL)OCTANE-1,8-DIAMINE
HETSYN NAG NAG HETSYN A8B TACRINE(8)-4-AMINOQUINOLINE
FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 4 A8B C30 H36 N4 FORMUL 5 HOH *153(H2 O)
HELIX 1 1 VAL A 40 ARG A 44 5 5 HELIX 2 2 PHE A 78 MET A 83 1 6 HELIX 3 3 LEU A 127 ASN A 131 5 5 HELIX 4 4 GLY A 132 GLU A 140 1 9 HELIX 5 5 VAL A 150 LEU A 156 1 7 HELIX 6 6 ASN A 167 ILE A 184 1 18 HELIX 7 7 GLN A 185 PHE A 187 5 3 HELIX 8 8 SER A 200 SER A 212 1 13 HELIX 9 9 SER A 215 PHE A 219 5 5 HELIX 10 10 VAL A 238 LEU A 252 1 15 HELIX 11 11 SER A 258 LYS A 269 1 12 HELIX 12 12 LYS A 270 GLU A 278 1 9 HELIX 13 13 TRP A 279 LEU A 282 5 4 HELIX 14 14 SER A 304 GLY A 312 1 9 HELIX 15 15 GLY A 328 ALA A 336 1 9 HELIX 16 16 SER A 348 VAL A 360 1 13 HELIX 17 17 ASN A 364 THR A 376 1 13 HELIX 18 18 ASN A 383 VAL A 400 1 18 HELIX 19 19 VAL A 400 GLY A 415 1 16 HELIX 20 20 PRO A 433 GLY A 437 5 5 HELIX 21 21 GLU A 443 PHE A 448 1 6 HELIX 22 22 GLY A 449 VAL A 453 5 5 HELIX 23 23 VAL A 453 ASN A 457 5 5 HELIX 24 24 THR A 459 GLY A 480 1 22 HELIX 25 25 ARG A 517 GLN A 526 1 10 HELIX 26 26 GLN A 526 THR A 535 1 10
SHEET 1 AA 3 LEU A 7 THR A 10 0 SHEET 2 AA 3 GLY A 13 MET A 16 -1 O GLY A 13 N THR A 10 SHEET 3 AA 3 VAL A 57 ASN A 59 1 O TRP A 58 N MET A 16 SHEET 1 AB11 THR A 18 VAL A 22 0 SHEET 2 AB11 SER A 25 PRO A 34 -1 O SER A 25 N VAL A 22 SHEET 3 AB11 TYR A 96 VAL A 101 -1 O LEU A 97 N ILE A 33 SHEET 4 AB11 VAL A 142 SER A 145 -1 O LEU A 143 N TRP A 100 SHEET 5 AB11 THR A 109 ILE A 115 1 O THR A 110 N VAL A 142 SHEET 6 AB11 GLY A 189 GLU A 199 1 N ASP A 190 O THR A 109 SHEET 7 AB11 ARG A 221 GLN A 225 1 O ARG A 221 N ILE A 196 SHEET 8 AB11 ILE A 319 ASN A 324 1 O LEU A 320 N LEU A 224 SHEET 9 AB11 THR A 418 PHE A 423 1 O TYR A 419 N LEU A 321 SHEET 10 AB11 LYS A 501 LEU A 505 1 O ILE A 503 N PHE A 422 SHEET 11 AB11 VAL A 512 GLN A 514 -1 O HIS A 513 N PHE A 502 SHEET 1 AC 2 VAL A 236 SER A 237 0 SHEET 2 AC 2 VAL A 295 ILE A 296 1 N ILE A 296 O VAL A 236
SSBOND 1 CYS A 67 CYS A 94 1555 1555 2.08 SSBOND 2 CYS A 254 CYS A 265 1555 1555 2.02 SSBOND 3 CYS A 402 CYS A 521 1555 1555 2.04
LINK ND2 ASN A 59 C1 NAG A1536 1555 1555 1.46 LINK ND2 ASN A 416 C1 NAG A1537 1555 1555 1.45
CISPEP 1 SER A 103 PRO A 104 0 1.29
SITE 1 AC1 2 ASN A 59 SER A 61 SITE 1 AC2 1 ASN A 416 SITE 1 AC3 12 TYR A 70 TRP A 84 GLY A 118 TYR A 121 SITE 2 AC3 12 GLU A 199 TRP A 279 PHE A 330 TRP A 432 SITE 3 AC3 12 HIS A 440 HOH A2042 HOH A2101 HOH A2153
CRYST1 111.487 111.487 136.744 90.00 90.00 120.00 P 31 2 1 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008970 0.005179 0.000000 0.00000
SCALE2 0.000000 0.010357 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007313 0.00000